Cremophor EL
Hans A. J. Gelderblom, Jaap Verweij, Kees Nooter et al. · European Journal of Cancer · 2001
Cited by 1,655 works. doi:10.1016/s0959-8049(01)00171-x
Authors
References
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
- Hypersensitivity reactions from taxol.
- European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.
- Patient preferences for oral versus intravenous palliative chemotherapy.
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.
- Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
- Central Nervous System Toxicity after Liver Transplantation
- Cardiac disturbances during the administration of taxol.
- Clinical toxicities encountered with paclitaxel (Taxol).
- Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.